Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
October 20 2022 - 8:30AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development of Intravascular Lithotripsy (IVL) to treat complex
calcified cardiovascular disease, will report financial results for
the third quarter 2022 after market close on Monday, November 7,
2022. Company management will host a corresponding conference call
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Interested parties may access live and archived webcasts of
these events on the "Investors" section of the company’s website at
https://ir.shockwavemedical.com. Investors interested
in listening to the third quarter 2022 Shockwave Medical earnings
conference call on Monday November 7, 2022, at 1:30 p.m. Pacific
Time / 4:30 p.m. Eastern Time may do so by dialing 877-704-4453 for
domestic callers or 201-389-0920 for international callers, using
conference ID:13733213.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing
products intended to transform the way calcified cardiovascular
disease is treated. The company aims to establish a new standard of
care for the interventional treatment of atherosclerotic
cardiovascular disease through differentiated and proprietary local
delivery of sonic pressure waves for the treatment of calcified
plaque, which the company refers to as Intravascular Lithotripsy
(IVL). IVL is a minimally invasive, easy-to-use and safe way to
significantly improve patient outcomes. To view an animation of the
IVL procedure and for more information, visit
www.shockwavemedical.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Apr 2023 to Apr 2024